i-Base home
Search Menu
  • Home
  • HTB
  • 2009
  • August
  • 22

22 August 2009

Contents

Conference reports

  • XVIII International Drug Resistance Workshop, 9-13 June 2009, Florida
  • Transmitted multidrug-resistant HIV persists in PBMC DNA for years
  • Low-level Q148R in people without integrase inhibitor experience
  • Cut-offs suggested for predicting efavirenz failure with low-level K103N
  • Lower M184V rates with FTC/TDF than with 3TC/TDF
  • HBV resistance to lamivudine at undetectable and low levels of viremia

Antiretrovirals

  • Raltegravir approved in the US for treatment-naive patients: paranoia and anxiety added as side effects

Guidelines

  • UK (BHIVA) guidelines online for comment (2009)

TB coinfection

  • TMC207 reduces time to sputum conversion in phase II trial on patients with drug-resistant TB

Basic science and immunology

  • Maximum suppression: ART intensification does not reduce residual viral load
  • The role of Ad5-specific CD4 T-cells in enhancing risk of HIV acquisition in the Merck vaccine trial
  • Tracing HIV reservoirs
  • Illuminating early events in HIV infection using single genome amplification
  • HTB RSS

Early access

  • Global Fund plans for lenacapavir PrEP in selected countries 9 July 2025
  • AIDS quilts at the Tate: reflection and also anger 8 July 2025
  • US government has altered more than 100 scientific databases since 20 January 5 July 2025
  • All early access reports

Current issues

  • July 2025
  • June 2025
  • May 2025
  • Back issues

Special report

  • AIDS quilts at the Tate: reflection and also anger 8 July 2025

More from HTB

  • Conference reports
  • Conference shortcuts
  • Articles by subject
  • PDFs
  • Subscribe
  • HTB homepage

Home

  • i-Base homepage
  • Donate

This website sets no cookies from us or anyone else.

Information on this website is provided by treatment advocates and offered as a guide only. Decisions about your treatment should always be taken in consultation with your doctor.

HIV i-BASE
About us - Contact - Cookies and privacy - Copyright waiver - Terms of use - Home
Registered charity number: 1081905. Company number: 3962064.

Search i-Base

Site navigation

Quick links
HIV positive
Donate
Feedback
Advice and information
Q and A
Guides
HIV meds
Glossary
Research reports
HTB
HTB South
Pipeline report
Publications and resources
Publications
Other resources
Translations
Slide sets
Order and subscribe
Advocates' network
UK-CAB
Training manual
i-Base
About us
Contact
News and updates
Sitemap
Home
Find us on Facebook
i-Base on Facebook